Polymerase Chain Reaction News and Research

RSS
Polymerase chain reaction (PCR) is a revolutionary laboratory technique that enables the replication of a specific DNA sequence. Using PCR, millions of copies of a target DNA can be easily synthesized within a short period of time.
Israeli study confirms drop in BNT162b2 efficacy after six months

Israeli study confirms drop in BNT162b2 efficacy after six months

Study suggests increased vaccine breakthrough for SARS-CoV-2 Omicron variant in Houston, Texas

Study suggests increased vaccine breakthrough for SARS-CoV-2 Omicron variant in Houston, Texas

Characteristics and outcomes in patients hospitalized with COVID-19 in South Africa

Characteristics and outcomes in patients hospitalized with COVID-19 in South Africa

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Modeling shows SARS-CoV-2 Omicron will place a severe burden on UK's health services

Modeling shows SARS-CoV-2 Omicron will place a severe burden on UK's health services

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

Omicron surges in England especially in young

Omicron surges in England especially in young

Less severe clinical consequences of infection with SARS-CoV-2 Omicron variant

Less severe clinical consequences of infection with SARS-CoV-2 Omicron variant

SARS-CoV-2 omicron variant may be less severe than the delta variant

SARS-CoV-2 omicron variant may be less severe than the delta variant

Antibody neutralization of SARS-CoV-2 Omicron variant via BNT162b2 vaccine booster dose

Antibody neutralization of SARS-CoV-2 Omicron variant via BNT162b2 vaccine booster dose

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

Omicron analysis shows no clear evidence for increased virulence or lethality

Omicron analysis shows no clear evidence for increased virulence or lethality

MRNA boosters shown to increase protection against SARS-CoV-2 Omicron

MRNA boosters shown to increase protection against SARS-CoV-2 Omicron

Study suggests saliva swabs may be more suitable for omicron detection

Study suggests saliva swabs may be more suitable for omicron detection

New strategy to create a cheap and rapid COVID-19 test based on isothermal amplification

New strategy to create a cheap and rapid COVID-19 test based on isothermal amplification

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

Allele-specific RT-qPCR assay to identify SARS-CoV-2 Omicron variant in wastewater

Allele-specific RT-qPCR assay to identify SARS-CoV-2 Omicron variant in wastewater

Coinfection of SARS-CoV-2 and human rhinovirus associated with more severe health outcomes

Coinfection of SARS-CoV-2 and human rhinovirus associated with more severe health outcomes

Assessing the clinical severity of the SARS-CoV-2 Omicron variant

Assessing the clinical severity of the SARS-CoV-2 Omicron variant

More breakthrough infections but less severe COVID-19 with Omicron

More breakthrough infections but less severe COVID-19 with Omicron

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.